Filing Details
- Accession Number:
- 0000911916-16-000699
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-05 16:39:43
- Reporting Period:
- 2016-12-01
- Filing Date:
- 2016-12-05
- Accepted Time:
- 2016-12-05 16:39:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1348649 | Colucid Pharmaceuticals Inc. | CLCD | Pharmaceutical Preparations (2834) | 203419541 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1639972 | C. Linda Hogan | C/O Colucid Pharmaceuticals, Inc. 222 Third Street Cambridge MA 02142 | Head, Bus. Dev. And Strategy | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-12-01 | 719 | $6.75 | 719 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-12-01 | 719 | $35.22 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-12-05 | 186 | $7.56 | 186 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-12-05 | 186 | $38.75 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-12-05 | 1,678 | $10.00 | 1,678 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-12-05 | 1,678 | $38.75 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-12-01 | 719 | $0.00 | 719 | $6.75 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-12-05 | 186 | $0.00 | 186 | $7.56 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-12-05 | 1,678 | $0.00 | 1,678 | $10.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,312 | 2026-03-04 | No | 4 | M | Direct | |
| 5,926 | 2025-08-04 | No | 4 | M | Direct | |
| 48,643 | 2025-05-05 | No | 4 | M | Direct |
Footnotes
- Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Ms. Hogan on March 24, 2016.
- Represents the sale of 719 shares in multiple transactions, ranging in price from $35.00 to $35.45 per share, resulting in a weighted average sale price of $35.2191. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- Options vest in a series of 48 successive equal monthly installments with the first monthly installment vesting on the grant date and the future installments vesting on the first day of each calendar month.
- Options vest as follows: one-third of the shares vested on August 4, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service.
- Options vest as follows: 33% of the shares vested on May 5, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service.
Billionaire Hedge Funds
